1. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound
- Author
-
Kiyonaka, Shigeki, Kato, Kenta, Nishida, Motohiro, Mio, Kazuhiro, Numaga, Takuro, Sawaguchi, Yuichi, Yoshida, Takashi, Wakamori, Minoru, Mori, Emiko, Numata, Tomohiro, Ishii, Masakazu, Takemoto, Hiroki, Ojida, Akio, Watanabe, Kenta, Uemura, Aya, Kurose, Hitoshi, Morii, Takashi, Kobayashi, Tsutomu, Sato, Yoji, Sato, Chikara, Hamachi, Itaru, and Mori, Yasuo
- Subjects
Pyrazoles -- Properties ,Pyrazoles -- Influence ,Ion channels -- Properties ,Ion channels -- Influence ,Cellular signal transduction -- Research ,Cell receptors -- Properties ,Biochemistry -- Research ,Calcium, Dietary -- Properties ,Calcium, Dietary -- Influence ,Science and technology - Abstract
Canonical transient receptor potential (TRPC) channels control influxes of [Ca.sup.2+] and other cations that induce diverse cellular processes upon stimulation of plasma membrane receptors coupled to phospholipase C (PLC). Invention of subtype-specific inhibitors for TRPCs is crucial for distinction of respective TRPC channels that play particular physiological roles in native systems. Here, we identify a pyrazole compound (Pyr3), which selectively inhibits TRPC3 channels. Structure-function relationship studies of pyrazole compounds showed that the trichloroacrylic amide group is important for the TRPC3 selectivity of Pyr3. Electrophysiological and photoaffinity labeling experiments reveal a direct action of Pyr3 on the TRPC3 protein. In DT40 B lymphocytes, Pyr3 potently eliminated the [Ca.sup.2+] influx-dependent PLC translocation to the plasma membrane and late oscillatory phase of B cell receptor-induced [Ca.sup.2+] response. Moreover, Pyr3 attenuated activation of nuclear factor of activated T cells, a [Ca.sup.2+]-dependent transcription factor, and hypertrophic growth in rat neonatal cardiomyocytes, and in vivo pressure overload-induced cardiac hypertrophy in mice. These findings on important roles of native TRPC3 channels are strikingly consistent with previous genetic studies. Thus, the TRPC3-selective inhibitor Pyr3 is a powerful tool to study in vivo function of TRPC3, suggesting a pharmaceutical potential of Pyr3 in treatments of TRPC3-related diseases such as cardiac hypertrophy. [Ca.sup.2+] signaling | pyrazole compounds | TRPC channels | TRPC3
- Published
- 2009